At a glance
CDC experts and funded research have helped to advance the field of lupus in many ways. These scientific articles about systemic lupus erythematosus, often referred to as lupus, are examples of recent and influential work that has come out of CDC's funded and expert activities.
Most recent publications
2024
Corbitt K, Carlucci PM, Cohen B, et al. Clinical and serologic phenotyping and damage indices in patients with systemic lupus erythematosus with and without fibromyalgia. ACR Open Rheumatol. 2024 Jan 9. doi: 10.1002/acr2.11641. Epub ahead of print
Barglund-Heglund D, Roberts E, Park J, E. Economic insecurities and patient-reported outcomes in patients with systemic lupus erythematosus in the USA: a cross-sectional analysis of data from the California Lupus Epidemiology Study. Lancet Rheum. 2024 Feb; 6(2):e105-e114.doi: 10.1016/S2665-9913(23)00296-5
2023
Aguirre A, Izadi Z, Trupin L, et al.Race, ethnicity, and disparities in risk of end-organ lupus manifestations following SLE diagnosis in a multiethnic cohort. Arthritis Care Res (Hoboken). 2023 Jan; 75(1):34-43. doi: 10.1002/acr.24892
Taylor T, Anastasiou C, and Clairissa J, et al. Cases of death among individuals with systemic lupus erythematosus by race and ethnicity: a population-based study. Arthritis Care Res (Hoboken). 2023 Jan; 75(1):61-68. doi: 10.1002/acr.24988
Chevet B, Figueroa-Parra G, Valenzuela-Almada MO, et al. Health care utilization in systemic lupus erythematosus in the community: The Lupus Midwest Network. J Clin Rheumatol. 2023 Jan 1; 29(1):29-35. doi:10.1097/RHU.0000000000001899
Garg S, Bartels CM, Bao G, et al. Timing and predictors of incident cardiovascular disease in systemic lupus erythematosus: risk occurs early and highlights racial disparities. J Rheumatol. 2023 Jan; 50(1):84-92. doi: 10.3899/jrheum.220279
Falasinnu T, Bao G, Brady TJ, et al. Factors Associated with the Initiation and Retention of Patients with Lupus in the Chronic Disease Self-Management Program. Arthritis Care Res (Hoboken). 2023 Mar;75(3):519-528.
Hocaoglu M, Valenzuela-Almada MO, NY, et al. Incidence, prevalence, and mortality of lupus nephritis: a population-based study over four decades-The Lupus Midwest Network (LUMEN). Arthritis Rheumatol. 2023 Apr; 75(4):567-573.
Figueroa-Parra G, Jeffery MM, et al. Long-term opioid therapy among patients with systemic lupus erythematosus in the community: A Lupus Midwest Network (LUMEN) Study. J Rheumatol. 2023 Apr; 50(4):504-511.
Guttmann A, Denvir B, Yearlings M, et al. Evaluation of the European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in a population based registry. Arthritis Care Res (Hoboken). 2023 May;75(5):1007-1016.
Minhas D, Marder W, Hassett AL, et al. Cost-related prescription non-adherence and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance program. Lupus. 2023 Aug; 32(9):1075-1083. doi: 10.1177/09612033231186113
Figueroa-Parra G, Meade-Aguilar JA, et al. Multimorbidity in systemic lupus erythematosus in a population-based cohort: the lupus Midwest network. Rheumatology (Oxford). 2023 Nov 24. doi: 10.1093/rheumatology/kead617. Epub ahead of print
Aguirre A, DeQuattro K, Shiboski S, et al. Medication cost concerns and disparities in patient-reported outcomes among a multiethnic cohort of patients with systemic lupus erythematosus. J Rheumatol. 2023 Oct; 50(10):1302-1309. doi: 10.3899/jrheum.2023-0060
Katz P, Patterson SL, DeQuattro K, et al. The association of trauma with self-reported flares and disease activity in systemic lupus erythematosus (SLE). Rheumatology (Oxford). 2023 Aug 1; 62(8):2780-2788. doi: 10.1093/rheumatology/keac690
Patterson S, Trupin L, Hartogensis W, et al. Perceived stress independently predicts worse disease activity and symptoms in a multi-racial/ethnic systemic lupus cohort. Arthritis Care Res (Hoboken). 2023 Aug; 75(8):1681-1689. doi: 10.1002/acr.25076
Hasan G, Ferucci ED, Buyon JP, ET. Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program. Rheumatology (Oxford). 2023 Aug 1; 62(8):2845-2849. doi: 10.1093/rheumatology/keac703
Somers EC, Goodrich JM, Wang L, . Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program. J Autoimmun. 2023 Dec 7;142:103137. doi: 10.1016/j.jaut.2023.103137. Epub ahead of print
2022
Drenkard C, Easley K, Bao G, et al. Cross-sectional study of the effects of self-efficacy on fatigue and pain interference in black women with systemic lupus erythematosus: the role of depression, age and education. Lupus Sci Med. 2022 Feb; 9(1):e000566. doi: 10.1136/lupus-2021-000566
Plantinga LC, Hoge C, Dunlop-Thomas C, et al. Association of COVID-19 pandemic-related concern and health routine changes with functioning among individuals with systemic lupus erythematosus. Lupus Sci Med. 2022 Feb; 9(1):e000658. doi: 10.1136/lupus-2022-000658
Perez RK, Subramaniam M, Gordon MG, et al.Single cell RNA-sequencing of 1.2 million cells reveals the cellular and genetic correlates of systemic lupus erythematosus. Science. 2022 Apr 8; 376(6589):eabf1970. doi: 10.1126/science.abf1970
Duarte-García A, Hocaoglu M, Valenzuela-Almada M, et al. Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades. Ann Rheum Dis. 2022 May 16:annrheumdis-2022-222276. doi: 10.1136/annrheumdis-2022-222276
Valenzuela-Almada MO, Hocaoglu M, et al. Epidemiology of childhood-onset systemic lupus erythematosus: a population-based study. Arthritis Care Res (Hoboken). 2022 May; 74(5):728-732. doi: 10.1002/acr.24827
Bridges J, Chung KW, Martz CD, et al. Leukocyte telomere length and childhood onset of systemic lupus erythematosus in the black women's experiences living with lupus study. ACR Open Rheumatol. 2022 May; 4(5):426-431. doi: 10.1002/acr2.11411
Duarte-García A, Hocaoglu M, Osei-Onomah SA, et al. Population-based incidence and time to classification of systemic lupus erythematosus by three different classification criteria: a Lupus Midwest Network (LUMEN) study. Rheumatology (Oxford). 2022 May 30; 61(6):2424-2431. doi: 10.1093/rheumatology/keab807
DeQuattro K, Trupin L, Murphy LB, et al. High disease severity among Asians in a US multiethnic cohort of individuals with systemic lupus erythematosus. Arthritis Care and Res (Hoboken). 2022 Jun; 74(6):896-903. doi: 10.1002/acr.24544
Angley M, Drews-Botsch C, Lewis TT, et al. Adverse Perinatal Outcomes Before and After Diagnosis of Systemic Lupus Erythematosus Among African American Women. Arthritis Care Res (Hoboken). 2022 Jun;74(6):904-911. doi: 10.1002/acr.24848
Patterson SL, Trupin L, Yazdany J, et al. Physical inactivity independently predicts incident depression in a multi-racial/ethnic systemic lupus cohort. Arthritis Care Res (Hoboken). 2022 Jul; 74(7):1098-1104. doi: 10.1002/acr.24555
Drenkard C, Barbour KE, Greenlund KJ, et al. The burden of living with cutaneous lupus erythematosus. Front Med (Lausanne). 2022 Aug 8;9:897987. doi: 10.3389/fmed.2022.897987
Drenkard C, Theis KA, Daugherty TT, et al. Depression, stigma and social isolation: the psychosocial trifecta of primary chronic cutaneous lupus erythematosus, a cross-sectional and path analysis. Lupus Sci Med. 2022 Aug; 9(1):e000697. doi: 10.1136/lupus-2022-000697
Chevet B, Figueroa-Parra G, the JX, et al. Utilization of preventive services in a systemic lupus erythematosus population-based cohort: a Lupus Midwest Network (LUMEN) study. Arthritis Res Ther. 2022 Sep 1; 24(1):211. doi: 10.1186/s13075-022-02878-8
Chevet B, Figueroa-Parra G, the JX, et al. COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN). J Rheum. 2022 Nov; 49(11):1276-1282. doi: 10.3899/jrheum.220220
2021
Katz P, Dall'Era M, Trupin L, Rush S, Murphy LB, Lanata C, Criswell LA, Yazdany J. The impact of limited health literacy on patient-reported outcomes in systemic lupus erythematosus. Arthritis Care Research. 2021 Jan; 73(1):110-119. doi: 10.1002/acr.24361
Dietz B, Katz P, Dall'Era M, Murphy L, et al. Depression and the patient reported outcomes measurement information system in systemic lupus erythematosus. Arthritis Care Res. 2021 Jan; 73(1):48-54. doi: 10.1002/acr
Plantinga L, Vandenberg A, Goldstein F, Jones B, Johnson J, Bowling CB, Dunlop-Thomas C, Lim SS, Drenkard C. Patient and provider perceptions of a novel cognitive functioning report for patients with systemic lupus erythematosus: a qualitative study. Lupus Sci Med. 2021 Feb; 8(1):e000476. doi: 10.1136/lupus-2021-000476
Gianfrancesco MA, Dall'Era M, Murphy LB, et al. Mortality among minority populations with systemic lupus erythematosus, including Asian and Hispanic/Latino persons — California, 2007–2017. MMWR Morb Mortal Wkly Rep. 2021 Feb 19; 70:236–239. doi: 10.15585/mmwr.mm7007a2
Izmirly PM, Parton H, Wang L, et al. Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis and Rheumatology. 2021 Jun; 73(6):991-996. doi: 10.1002/art.41632
Hunter EA, Spears EC, Martz CD, et al. Racism-related stress and psychological distress: Black Women's Experiences Living with Lupus study. J Health Psychol. 2021 Nov; 26(13):2374-2389. doi: 10.1177/135910532091308
Izmirly PM, Ferucci ED, Somers EC, et al. Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries. Lupus Sci Med. 2021 Dec; 8(1):e000614.doi: 10.1136/lupus-2021-000614
2020
DeQuattro K, Trupin L, Li J, et al. Relationships between adverse childhood experiences and health status in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2020; 72(4):525-533. doi: 10.1002/acr.23878
Charoenwoodhipong P, Harlow S, Marder W, et al. Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: the Michigan Lupus Epidemiology & Surveillance Program. Arthritis Care Res (Hoboken). 2020;72(7):874-881. doi: 10.1002/acr.23925
2019
Somers EC, Lee J, Hassett AL, et al. Prescription opioid use in patients with and without systemic lupus erythematosus—Michigan Lupus Epidemiology and Surveillance Program 2014-2015. MMWR Morb Mortal Wkly Rep. 2019; 68(38):819-824. doi: 10.15585/mmwr.mm6838a2
Lim SS, Helmick CG, Bao G, et al. Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus—Fulton and DeKalb Counties, Georgia, 2002-2016. MMWR Morb Mortal Wkly Rep. 2019; 68(18):419-422. doi: 10.15585/mmwr.mm6818a4
2018
Erica Heiman, S. Sam Lim, Gaobin Bao, et al. Depressive symptoms are associated with low treatment adherence in African American individuals with systemic lupus erythematosus. Journal of Clinical Rheumatology. 2018; 24(7):368-374. doi: 10.1097/RHU.0000000000000794
2017
Dall'era M, Cisternas MG, Snipes K, et al. The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: the California Lupus Surveillance Project. Arthritis Rheumatol. 2017; 69(10):1996-2005. doi: 10.1002/art.40191.
Izmirly PM, Wan I, Sahl S, et al. The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan Lupus Surveillance Program. Arthritis Rheumatol. 2017; 69(10):2006-2017. doi: 10.1002/art.40192
Plantinga L, Lim SS, Patzer R, et al. Incidence of end-stage renal disease among newly diagnosed systemic lupus erythematosus patients: the Georgia Lupus Registry. Arthritis Care Res (Hoboken). 2017;68:357-365. doi: 10.1002/acr.22685
2016
Ferucci ED, Johnston JM, Gordon C, et al. Prevalence of mixed connective tissue disease in a population-based registry of American Indian/Alaska Native people in 2007. Arthritis Care Res (Hoboken). 2016;69:1271-1275. doi:10.1002/acr.23135
2015
Housey M, Deguire P, Lyon-Callo S, et al. Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program. Am J Public Health. 2015; 105(5):e74-9. doi: 10.2105/AJPH.2014.302423
2014
Ferucci ED, Johnston JM, Gaddy JR, et al. Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009. Arthritis Rheumatol. 2014; 66(9):2492-2502. doi: 10.1002/art.38720
Lim SS, Bayakly AR, Helmick CG, et al. The incidence and prevalence of systemic lupus erythematosus, 2002–2004: The Georgia Lupus Registry. Arthritis Rheumatol. 2014; 66(2):357–368. doi: 10.1002/art.38239
Somers EC, Marder W, Cagnoli P, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance Program. Arthritis Rheumatol. 2014; 66(2):369–378. doi: 10.1002/art.38238
2012
Drenkard C, Dunlop-Thomas C, Easley K, et al. Benefits of the chronic disease self-management program in low income African American women with systemic lupus erythematous: results of a pilot test. Lupus. 2012; 21(14):1586–1593. doi:10. 1177/0961203312458842
2009
Lim S, Drenkard C, McCune WJ, et al. Population-based lupus registries: advancing our epidemiologic understanding. Arthritis Rheum. 2009; 61(10):1462–1466. doi: 10.1002/art.24835
2002
Sacks JJ, Helmick CG, Langmaid G, et al. Trends in deaths from systemic lupus erythematosus—United States, 1979–1998. MMWR Morb Mortal Wkly Rep. 2002; 51(17): 371–374.